Evidence map›Paper›PMID 23394511›Full record

ArticleAllergy and asthma proceedings

Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis.

John Leung, Ann Nguyen-Traxler, Erika M Lee, Jason S Yip, Joel V Weinstock, Walter W Chan, Peter Ngo, Barbara J Weinstein, Peter A Bonis

Erratum issuedOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Allergy and asthma proceedings. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Minimally invasive biomarker studies in eosinophilic esophagitis: A systematic review.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2018
    Pooled it
  2. Trial
  3. Shifting the scope: Moving toward less invasive diagnosis and monitoring of eosinophilic esophagitis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2026
    Review
  4. Emerging Tissue and Blood Biomarkers for Eosinophilic Esophagitis.Gastroenterology clinics of North America · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Noninvasive tests for eosinophilic esophagitis: Ready for use?Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Review
  11. Non-invasive biomarkers of eosinophilic esophagitis.Acta bio-medica : Atenei Parmensis · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Non- and semi-invasive methods of monitoring eosinophilic esophagitis.Digestive diseases (Basel, Switzerland) · 2014
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

John LeungDepartment of Rheumatology, Immunology and Allergy, Harvard Medical School/Massachusetts General Hospital, Boston, MA 02114, USA. jleung7@partners.org
Ann Nguyen-Traxler
Erika M Lee
Jason S Yip
Joel V Weinstock
Walter W Chan
Peter Ngo
Barbara J Weinstein
Peter A Bonis
Tufts Medical Center · USBrigham and Women's Hospital · USMassachusetts General Hospital · USTufts Children's Hospital · US

Funding

TUFTS CLINICAL AND TRANSLATION SCIENCE INSTITUTE (UL1): BPCAUL1RR025752 · NCRR · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2008 to 2011
$17.6M
PATHOBIOLOGY OF DIGESTIVE DISEASEST32DK007542 · NIDDK · TUFTS UNIVERSITY BOSTON · PI LISCUM, LAURA · 1986 to 2010
$3.5M
NCRR NIH HHS UL1 RR025752NIDDK NIH HHS T32 DK007542NIDDK NIH HHS T32DK007542
6 · The paper itself

Abstract

Diagnosis of eosinophilic esophagitis (EoE) and determination of response to therapy is based on histological assessment of the esophagus, which requires upper endoscopy. In children, in whom a dietary approach is commonly used, multiple endoscopies are needed, because foods are eliminated and then gradually reintroduced. Ideally, noninvasive methods could supplement or replace upper endoscopy to facilitate management. Fractionated exhaled nitric oxide (FeNO) has been proposed as a useful measure for monitoring disease activity in studies of patients with eosinophil-predominant asthma and in other atopic disorders. Thus, we evaluated whether FeNO levels could be a useful biomarker to assess the response to therapy in EoE patients. This study was designed to determine whether there is a change in FeNO levels during treatment with topical corticosteroids and whether changes correlated with clinical response. This was a prospective, multicenter study that enrolled nonasthmatic patients with established EoE. FeNO levels and symptom scores were measured at baseline, biweekly during 6-week swallowed fluticasone treatment, and 4 weeks posttreatment. Twelve patients completed the trial. We found a statistically significant difference between median pre- and posttreatment FeNO levels [20.3 ppb (16.0 -29.0 ppb) vs 17.6 ppb (11.7 -27.3 ppb), [corrected] p=0.009]. However, neither the pretreatment FeNO level, a change of FeNO level after 2 weeks of treatment, nor the FeNO level at the end of treatment confidently predicted a clinical or histological response. Although our findings suggest nitric oxide possibly has a physiological role in EoE, our observations do not support a role of FeNo determination for management of EoE.

Indexed as

AdolescentAdultAgedBiomarkersChildEosinophilic EsophagitisExhalationFemaleHumansMaleMiddle AgedNitric OxidePilot ProjectsProspective StudiesYoung AdultBiomarkersNitric Oxide

Identifiers

PMID23394511
PMCPMC3522397
OpenAlexW2132006295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.